Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 1

Conditions

Sarcoma 286Gliosarcoma 149Glioblastoma 149Brain Neoplasms 90Osteosarcoma 84Glioma 68Gastrointestinal Stromal Tumors 68Rhabdomyosarcoma 65Lymphoma, Non-Hodgkin 59Astrocytoma 59Recurrence 57Dendritic Cell Sarcoma, Interdigitating 57Sarcoma, Ewing 55Neoplasms 54Precursor Cell Lymphoblastic Leukemia-Lymphoma 50Lymphoma 50Burkitt Lymphoma 49Central Nervous System Neoplasms 48Neuroblastoma 47Lymphoma, Large B-Cell, Diffuse 47Lymphoma, Follicular 46Neoplasm Metastasis 45Lymphoma, Mantle-Cell 45Leiomyosarcoma 44Oligodendroglioma 43Leukemia, Myeloid, Acute 43Liposarcoma 42Lymphoma, B-Cell, Marginal Zone 41Leukemia, Lymphocytic, Chronic, B-Cell 41Hodgkin Disease 41

Interventions

Temozolomide 1Irinotecan 1FANG vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Neoplasms, Connective and Soft Tissue × Sarcoma × Clear all
NCT05160168 2024-06-05

A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Theseus Pharmaceuticals

Phase 1/2 Terminated
32 enrolled 20 charts
GastrointestinalSarcoma

Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective Tissue, Neoplasms, Connective and Soft Tissue, Gastrointestinal Stromal Tumors

NCT03495921 2023-04-26

VITA

Gradalis, Inc.

Phase 3 Terminated
32 enrolled 13 charts
Sarcoma

Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective Tissue, Sarcoma, Sarcoma, Ewing, Neoplasms, Connective and Soft Tissue, Neoplasms, Bone Tissue, Neuroectodermal Tumors, Primitive, Peripheral, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡